IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 244 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,098,315 | -66.8% | 241,388 | -48.6% | 0.00% | -100.0% |
| Q2 2023 | $3,307,476 | +26.8% | 469,812 | +10.1% | 0.00% | 0.0% |
| Q1 2023 | $2,607,864 | -48.8% | 426,819 | -46.5% | 0.00% | -50.0% |
| Q4 2022 | $5,097,189 | +400.7% | 797,682 | +650.8% | 0.00% | – |
| Q3 2022 | $1,018,000 | -2.6% | 106,239 | +12.3% | 0.00% | – |
| Q2 2022 | $1,045,000 | -82.6% | 94,639 | -73.7% | 0.00% | -100.0% |
| Q1 2022 | $5,990,000 | +42.9% | 359,746 | +63.9% | 0.00% | +100.0% |
| Q4 2021 | $4,191,000 | -13.4% | 219,537 | +11.8% | 0.00% | -50.0% |
| Q3 2021 | $4,840,000 | +197.5% | 196,284 | +213.8% | 0.00% | +100.0% |
| Q2 2021 | $1,627,000 | -47.5% | 62,542 | -36.1% | 0.00% | 0.0% |
| Q1 2021 | $3,097,000 | -22.0% | 97,848 | +14.3% | 0.00% | 0.0% |
| Q4 2020 | $3,973,000 | +67.6% | 85,629 | +19.0% | 0.00% | 0.0% |
| Q3 2020 | $2,370,000 | +90.7% | 71,979 | +58.9% | 0.00% | 0.0% |
| Q2 2020 | $1,243,000 | +49.4% | 45,294 | +62.9% | 0.00% | – |
| Q1 2020 | $832,000 | -80.7% | 27,799 | -82.1% | 0.00% | -100.0% |
| Q4 2019 | $4,309,000 | -37.0% | 155,692 | -58.6% | 0.00% | -66.7% |
| Q3 2019 | $6,842,000 | +111.8% | 375,921 | +185.3% | 0.00% | +200.0% |
| Q2 2019 | $3,230,000 | +3195.9% | 131,759 | +1184.8% | 0.00% | – |
| Q1 2019 | $98,000 | -95.9% | 10,255 | -96.2% | 0.00% | -100.0% |
| Q4 2018 | $2,385,000 | +364.9% | 269,494 | +490.2% | 0.00% | – |
| Q3 2018 | $513,000 | +440.0% | 45,661 | +518.3% | 0.00% | – |
| Q2 2018 | $95,000 | -90.8% | 7,385 | -87.9% | 0.00% | – |
| Q1 2018 | $1,035,000 | +9309.1% | 61,222 | +4285.5% | 0.00% | – |
| Q4 2017 | $11,000 | -82.3% | 1,396 | -82.6% | 0.00% | – |
| Q3 2017 | $62,000 | -7.5% | 8,000 | -11.8% | 0.00% | – |
| Q2 2017 | $67,000 | – | 9,072 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 565,890 | $26,257,000 | 9.39% |
| Consonance Capital Management LP | 1,710,803 | $79,381,000 | 7.41% |
| GREAT POINT PARTNERS LLC | 917,427 | $42,569,000 | 6.91% |
| Avoro Capital Advisors LLC | 7,500,000 | $348,000,000 | 5.99% |
| Ghost Tree Capital, LLC | 500,000 | $23,200,000 | 5.17% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $60,923,000 | 4.69% |
| Perceptive Advisors | 9,166,304 | $425,316,000 | 4.56% |
| Ally Bridge Group (NY) LLC | 360,000 | $16,704,000 | 2.86% |
| Orbimed Advisors | 6,645,100 | $308,333,000 | 2.70% |
| ACUTA CAPITAL PARTNERS, LLC | 164,800 | $7,647,000 | 2.08% |